NAPLEX Practice Exam 2025 – Comprehensive Test Preparation

Question: 1 / 1820

Which of the following is NOT an indication for Palivizumab in children?

Premature infants born at < 29 months

Infants < 6 months with chronic lung disease

Palivizumab is a monoclonal antibody used to prevent severe lower respiratory tract infections caused by respiratory syncytial virus (RSV) in certain high-risk infants and children. The indications for Palivizumab include premature infants born at < 29 weeks, infants < 12 months with certain heart conditions, and premature infants born at < 32 weeks with chronic lung disease. However, infants < 6 months with chronic lung disease are not indicated for Palivizumab. This is why option B is the correct answer because it is the only one that does not represent a valid indication for Palivizumab use in children.

Get further explanation with Examzify DeepDiveBeta

Infants < 12 months with certain heart conditions

All are indications for Palivizumab

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy